An update on cardiac troponins as circulating biomarkers in heart failure

Current Heart Failure Reports

Volumn 7, Issue 1, 2010, Pages 15-21

  Masson, Serge ^a   Latini, Roberto ^a   Anand, Inder S ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Biomarkers; Heart failure; Prognosis; Troponin

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; TROPONIN; TROPONIN I; TROPONIN T;

ACUTE HEART FAILURE; ACUTE HEART INFARCTION; CARDIOVASCULAR RISK; CELL DAMAGE; CELL DEATH; CELL SECRETION; CHRONIC KIDNEY DISEASE; DIAGNOSTIC ACCURACY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HOSPITALIZATION; HUMAN; KIDNEY CLEARANCE; MORTALITY; NONHUMAN; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN SECRETION; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

CHRONIC DISEASE; HEART FAILURE; HUMANS; SENSITIVITY AND SPECIFICITY; TROPONIN I; TROPONIN T;

EID: 77949263553     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-010-0001-0     Document Type: Review

References (46)

1. K Thygesen JS Alpert HD White 2007 Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction: Universal definition of myocardial infarction Circulation 116 2634 2653 10.1161/CIRCULATIONAHA.107.187397 17951284 (Pubitemid 350182388)
2. AK Saenger AS Jaffe 2008 Requiem for a heavyweight: the demise of creatine kinase-MB: Circulation 118 2200 2206 19015414
3. • Keller T, Zeller T, Peetz D, et al.: Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009, 361:868-877. This clinical study shows that an hsTnI assay improves early diagnosis of acute MI compared with the traditional troponin assay, regardless of the time of chest pain onset.
4. • Reichlin T, Hochholzer W, Bassetti S, et al.: Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361:858-867. The diagnostic accuracy of four sensitive cardiac troponin assays is superior to a traditional assay in 718 consecutive patients who presented symptoms suggestive of acute MI in the emergency department.
5. HA Katus E Giannitsis AS Jaffe K Thygesen 2009 Higher sensitivity troponin assays: quo vadis? Eur Heart J 30 127 128 10.1093/eurheartj/ehn555 1:STN:280:DC%2BD1M%2FntFWitg%3D%3D 19074444
6. T Omland JA de Lemos MS Sabatine, et al. 2009 A sensitive cardiac troponin T assay in stable coronary artery disease N Engl J Med 361 2538 2547 10.1056/NEJMoa0805299 1:CAS:528:DC%2BC3cXls1Gm 19940289
7. • Kelley WE, Januzzi JL, Christenson RH: Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin Chem 2009, 55:2098-2112. This article provides a well-documented and comprehensive review on alternative causes of elevated cardiac troponins when acute coronary syndromes and heart failure are excluded.
8. L La Vecchia G Mezzena R Ometto, et al. 1997 Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin Am J Cardiol 80 88 90 10.1016/S0002-9149(97)00291-9 9205029 (Pubitemid 27274588)
9. E Missov C Calzolari B Pau 1997 Circulating cardiac troponin I in severe congestive heart failure Circulation 96 2953 2958 1:STN:280: DyaK1c%2FksF2huw%3D%3D 9386162
10. Y Sato T Yamada R Taniguchi, et al. 2001 Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes Circulation 103 369 374 1:CAS:528:DC%2BD3MXhtF2ksLo%3D 11157687
11. K Setsuta Y Seino T Ogawa, et al. 2002 Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure Am J Med 113 717 722 10.1016/S0002-9343(02)01394-3 1:CAS:528:DC%2BD3sXotVWg 12517360 (Pubitemid 36044696)
12. J Ishii M Nomura Y Nakamura, et al. 2002 Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure Am J Cardiol 89 691 695 10.1016/S0002-9149(01)02341-4 1:CAS:528:DC%2BD38XhvVWkur4%3D 11897211 (Pubitemid 34230565)
13. JS Healey RF Davies SJ Smith, et al. 2003 Prognostic use of cardiac troponin T and troponin I in patients with heart failure Can J Cardiol 19 383 386 1:CAS:528:DC%2BD3sXkvVCis7Y%3D 12704483
14. ER Perna SM Macin JP Canella, et al. 2004 Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification Circulation 110 2376 2382 10.1161/01.CIR. 0000145158.33801.F3 15477403 (Pubitemid 39407342)
15. J Ishii W Cui F Kitagawa, et al. 2003 Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure Clin Chem 49 2020 2026 10.1373/clinchem.2003.021311 1:CAS:528:DC%2BD3sXpt1yntrc%3D 14633873 (Pubitemid 37449474)
16. JP Bertinchant N Combes A Polge, et al. 2005 Prognostic value of cardiac troponin T in patients with both acute and chronic stable congestive heart failure: comparison with atrial natriuretic peptide, brain natriuretic peptide and plasma norepinephrine Clin Chim Acta 352 143 153 10.1016/j.cccn.2004.09.009 1:CAS:528:DC%2BD2MXkvFamtg%3D%3D 15653109 (Pubitemid 40093866)
17. WF Peacock 4th T De Marco GC Fonarow, et al. 2008 Cardiac troponin and outcome in acute heart failure N Engl J Med 358 2117 2126 10.1056/NEJMoa0706824 1:CAS:528:DC%2BD1cXlvFCrsrk%3D 18480204 (Pubitemid 351679598)
18. MP Hudson CM O'Connor WA Gattis, et al. 2004 Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis Am Heart J 147 546 552 10.1016/j.ahj.2003.10.014 1:CAS:528: DC%2BD2cXhslensLk%3D 14999208 (Pubitemid 38880881)
19. SM Dunlay Y Gerber SA Weston, et al. 2009 Prognostic value of biomarkers in heart failure: application of novel methods in the community Circ Heart Fail 2 393 400 10.1161/CIRCHEARTFAILURE.109.849299 1:CAS:528:DC%2BD1MXhtV2qs73E 19808368
20. J Sundström E Ingelsson L Berglund, et al. 2009 Cardiac troponin-I and risk of heart failure: a community-based cohort study Eur Heart J 30 773 781 10.1093/eurheartj/ehp047 19264749
21. CH Del Carlo AC Pereira-Barretto C Cassaro-Strunz, et al. 2004 Serial measure of cardiac troponin T levels for prediction of clinical events in decompensated heart failure J Card Fail 10 43 48 10.1016/S1071-9164(03)00594-3 14966774 (Pubitemid 38880891)
22. WL Miller KA Hartman MF Burritt, et al. 2009 Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure J Am Coll Cardiol 54 1715 1721 10.1016/j.jacc.2009.07.025 1:CAS:528:DC%2BD1MXhsFait7rI 19850213
23. FS Apple SW Smith LA Pearce, et al. 2008 Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome Clin Chem 54 723 728 10.1373/clinchem.2007.097162 1:CAS:528:DC%2BD1cXkt1equ7s%3D 18238833 (Pubitemid 351573705)
24. Giannitsis E, Kurz K, Hallermayer K, et al.: Analytical validation of high-sensitivity cardiac troponin T assay. Clin Chem 2009 Dec 3 (Epub ahead of print).
25. A Clerico A Fortunato A Ripoli, et al. 2008 Distribution of plasma cardiac troponin I values in healthy subjects: pathophysiological considerations Clin Chem Lab Med 46 804 808 10.1515/CCLM.2008.162 1:CAS:528: DC%2BD1cXot1eiu7w%3D 18601601 (Pubitemid 351821637)
26. P Venge N Johnston B Lindahl S James 2009 Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia J Am Coll Cardiol 54 1165 1172 10.1016/j.jacc.2009.05.051 1:CAS:528:DC%2BD1MXht1GntbfM 19761938
27. •• Latini R, Masson S, Anand IS, et al.: Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007, 116:1242-1249. This article offered the first evidence obtained in a large international clinical trial that hsTnT is an independent and robust prognostic marker in more than 4000 patients with chronic and symptomatic HF.
28. JN Cohn G Tognoni 2001 Valsartan Heart Failure Trial Investigators: A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 1667 1675 10.1056/NEJMoa010713 1:CAS:528: DC%2BD3MXovFKjtLc%3D 11759645 (Pubitemid 33126822)
29. D Logeart P Beyne C Cusson, et al. 2001 Evidence of cardiac myolysis in severe nonischemic heart failure and the potential role of increased wall strain Am Heart J 141 247 253 10.1067/mhj.2001.111767 1:STN:280:DC%2BD3M7osVOruw%3D%3D 11174339 (Pubitemid 32128730)
30. Y Sato K Nishi R Taniguchi, et al. 2009 In patients with heart failure and non-ischemic heart disease, cardiac troponin T is a reliable predictor of long-term echocardiographic changes and adverse cardiac events J Cardiol 54 221 230 10.1016/j.jjcc.2009.05.007 19782259
31. •• Braunwald E. Biomarkers in heart failure. N Engl J Med 2008, 358:2148-2159. This article provides an outstanding state-of-the-art review on biomarkers in HF.
32. G Olivetti G Giordano D Corradi, et al. 1995 Gender differences and aging: effects on the human heart J Am Coll Cardiol 26 1068 1079 10.1016/0735-1097(95)00282-8 1:STN:280:DyaK28%2Fgslemtw%3D%3D 7560601
33. JM Capasso A Malhotra P Li, et al. 1992 Chronic nonocclusive coronary artery constriction impairs ventricular function, myocardial structure, and cardiac contractile protein enzyme activity in rats Circ Res 70 148 162 1:STN:280:DyaK38%2FovF2rtw%3D%3D 1530779
34. G Olivetti R Abbi F Quaini, et al. 1997 Apoptosis in the failing human heart N Engl J Med 336 1131 1141 10.1056/NEJM199704173361603 1:STN:280:DyaK2s3jvVOmtg%3D%3D 9099657 (Pubitemid 27374695)
35. J Narula P Pandey E Arbustini, et al. 1999 Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy Proc Natl Acad Sci USA 96 8144 8149 10.1073/pnas.96.14.8144 1:CAS:528:DyaK1MXltVOrs7c%3D 10393962 (Pubitemid 29328422)
36. BE Sobel MM LeWinter 2000 Ingenuous interpretation of elevated blood levels of macromolecular markers of myocardial injury: a recipe for confusion J Am Coll Cardiol 35 1355 1358 10.1016/S0735-1097(00)00516-7 1:STN:280: DC%2BD3c3itVOgsg%3D%3D 10758980 (Pubitemid 30206912)
37. A Jeremias CM Gibson 2005 Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded Ann Intern Med 142 786 791 15867411
38. T Tsutamoto C Kawahara M Yamaji, et al. 2009 Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure Eur J Heart Fail 11 653 658 10.1093/eurjhf/hfp072 1:CAS:528:DC%2BD1MXotVKjtb8%3D 19502379
39. MC Fishbein T Wang M Matijasevic L Hong FS Apple 2003 Myocardial tissue troponins T and I. An immunohistochemical study in experimental models of myocardial ischemia Cardiovasc Pathol 12 65 71 10.1016/S1054-8807(02)00188-6 1:CAS:528:DC%2BD3sXislent7o%3D 12684160 (Pubitemid 36401579)
40. J Zhang A Knapton SE Lipshultz, et al. 2008 Isoproterenol-induced cardiotoxicity in sprague-dawley rats: correlation of reversible and irreversible myocardial injury with release of cardiac troponin T and roles of iNOS in myocardial injury Toxicol Pathol 36 277 278 10.1177/0192623307313010 18349426
41. FS Apple MM Murakami R Ler, et al. 2008 Analytical characteristics of commercial cardiac troponin I and T immunoassays in serum from rats, dogs, and monkeys with induced acute myocardial injury Clin Chem 54 1982 1989 10.1373/clinchem.2007.097568 1:CAS:528:DC%2BD1MXjtFejsA%3D%3D 18845772 (Pubitemid 352774031)
42. • O'Brien PJ: Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity. Toxicology 2008, 245:206-218. This review discusses why cardiac troponins are the preferred translational and safety biomarker for myocardial injury and cardiotoxicity in animal models.
43. C Prontera A Fortunato S Storti, et al. 2007 Evaluation of analytical performance of the Siemens ADVIA TnIultra immunoassay Clin Chem 53 1722 1723 10.1373/clinchem.2007.089995 1:CAS:528:DC%2BD2sXhtVSnsr%2FK 17712017 (Pubitemid 47340078)
44. PA Kavsak AR MacRae MJ Yerna AS Jaffe 2009 Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury Clin Chem 55 573 577 10.1373/clinchem.2008.116020 1:CAS:528:DC%2BD1MXivFaqt7s%3D 19168557
45. Hedberg P, Valkama J, Suvanto E, et al.: Evaluation of innotrac aio! Second-generation cardiac troponin I assay: the main characteristics for routine clinical use. J Autom Methods Manag Chem 2006, 2006:39325.
46. MS Sabatine DA Morrow JA de Lemos, et al. 2009 Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35 Eur Heart J 30 162 169 10.1093/eurheartj/ehn504 1:CAS:528:DC%2BD1MXotl2lsg%3D%3D 18997177